NASDAQ:TYHT Shineco (TYHT) Stock Price, News & Analysis → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free TYHT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range N/A50-Day Range$6.13▼$12.7552-Week Range N/AVolume3,062 shsAverage Volume464,215 shsMarket Capitalization$97.24 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Shineco alerts: Email Address Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. About Shineco Stock (NASDAQ:TYHT)Shineco, Inc. is a holding company, which through its subsidiaries, engages in the production and distribution of plant-based products. It operates through the following segments: Luobuma Products, Herbal Products, and Other Agricultural Products. The Luobuma Products segment focuses in the development, manufacture, and distribution of specialized fabrics, textile products, and other by-products derived from an indigenous Chinese plant called Apocynum Venetum. The Herbal Products segment involves in the processing and distribution of traditional Chinese medicinal herbal products as well as other pharmaceutical products. The Other Agricultural Products segment comprises planting, processing, and distribution of green and organic agricultural produce and growing and cultivating of Chinese Yew trees. The company was founded on August 20, 1997 and is headquartered in Beijing, China.Read More Ad Colonial MetalsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareThe latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. TYHT Stock News HeadlinesFebruary 22, 2024 | benzinga.comShineco Stock (NASDAQ:SISI) Earnings Dates and Earning CallsFebruary 15, 2024 | benzinga.comShineco Stock (NASDAQ:SISI) Dividends: History, Yield and DatesMay 4, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.February 3, 2024 | investing.comAslan Pharmaceuticals Ltd ADR (ASLN)November 17, 2023 | markets.businessinsider.comShineco Announces the Appointment of Two New Executive OfficersOctober 30, 2023 | finance.yahoo.comShineco Opens Healthy Food Restaurant with Focus on Advanced NutritionAugust 25, 2023 | finance.yahoo.comShineco (SISI): A Hidden Gem or a Value Trap?July 10, 2023 | finance.yahoo.comWhy Are Shineco Shares Trading Higher Today?May 4, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.July 10, 2023 | marketwatch.comShineco Shares Jump 33% on Approval for Cardiac TestJuly 10, 2023 | finance.yahoo.comShineco Subsidiary Receives Marketing Approval from China’s Regulatory Body for its Cardiac 5-Minute TestJanuary 9, 2023 | msn.comHow Is The Market Feeling About Shineco?December 7, 2022 | finance.yahoo.comShineco, Inc Subsidiary, Granted USPTO Patent and FDA Marketing Approval for Its In-situ Fecal Specimen Sampling DeviceOctober 26, 2022 | fool.comShineco, Inc. (NASDAQ: TYHT)October 25, 2022 | finance.yahoo.comShineco, Inc. to Acquire Controlling Equity Interest in Changzhou Biowin Pharmaceutical Co., Ltd to Step into Point-of-Care Testing IndustryJune 13, 2022 | marketscreener.comSHINECO, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) - Marketscreener.comJune 7, 2022 | uk.investing.comStocks That Hit 52-Week Lows On Monday By Benzinga - Investing.com UKApril 14, 2022 | finance.yahoo.comShineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of US$2.2 Million - Yahoo FinanceMarch 28, 2022 | globenewswire.comShineco, Inc. Announces Board and Officer Changes - GlobeNewswireMarch 18, 2022 | globenewswire.comShineco, Inc. Plans to Introduce a Private Equity Fund to Help its Business Transition - GlobeNewswireMarch 14, 2022 | rttnews.comPre-market Movers: VOLT, TRQ, ENSV, SBTX, MGLD… - RTTNewsMarch 13, 2022 | finance.yahoo.comShineco, Inc. to Build Its First Tumor Classification Diagnosis and Treatment Center in Weifang City, Shandong Province - Yahoo FinanceMarch 3, 2022 | globenewswire.comShineco, Inc. Announces New Website Launch - GlobeNewswireFebruary 24, 2022 | benzinga.comShineco To Create Industry-University-Research-Medical Collaborative Platform For Psychological Rehabilitation Of Tumor Patients - BenzingaFebruary 24, 2022 | globenewswire.comShineco, Inc. to Create an Industry-University-Research-Medical Collaborative Platform for Psychological Rehabilitation of Tumor Patients - GlobeNewswireFebruary 17, 2022 | globenewswire.comShineco, Inc. Announces Strategic Alliance to Enhance the - GlobeNewswireFebruary 11, 2022 | marketscreener.comShineco : Amendment to Annual Report (Form 10-K/A) - marketscreener.comSee More Headlines Receive TYHT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Shineco and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Agricultural Production - Crops Sub-IndustryN/A Current SymbolNASDAQ:TYHT CUSIPN/A CIK1300734 Webwww.tianyiluobuma.com Phone861087227366FaxN/AEmployees318Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-6,630,000.00 Net Margins-159.60% Pretax MarginN/A Return on Equity-37.00% Return on Assets-29.88% Debt Debt-to-Equity RatioN/A Current Ratio3.88 Quick Ratio3.71 Sales & Book Value Annual Sales$23.68 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book Value$21.90 per share Price / BookN/AMiscellaneous Outstanding Shares8,768,000Free FloatN/AMarket Cap$97.24 million OptionableNot Optionable Beta1.96 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesJennifer ZhanChief Executive Officer & Executive DirectorSam WangChief Financial Officer & DirectorKey Competitorsbluebird bioNASDAQ:BLUEDiaMedica TherapeuticsNASDAQ:DMACIMACNASDAQ:IMACVigil NeuroscienceNASDAQ:VIGLIO BiotechNASDAQ:IOBTView All Competitors TYHT Stock Analysis - Frequently Asked Questions When did Shineco's stock split? Shares of Shineco reverse split before market open on Monday, August 17th 2020. The 1-9 reverse split was announced on Thursday, August 13th 2020. The number of shares owned by shareholders was adjusted after the market closes on Friday, August 14th 2020. An investor that had 100 shares of stock prior to the reverse split would have 11 shares after the split. What other stocks do shareholders of Shineco own? Based on aggregate information from My MarketBeat watchlists, some companies that other Shineco investors own include SCYNEXIS (SCYX), Lockheed Martin (LMT), AbbVie (ABBV), Bausch Health Companies (BHC), Amicus Therapeutics (FOLD), NIO (NIO), Trevena (TRVN), Verastem (VSTM), Zynerba Pharmaceuticals (ZYNE) and AcelRx Pharmaceuticals (ACRX). This page (NASDAQ:TYHT) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldInvestors Alert: The Next Big Thing in Weight LossBehind the MarketsElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithStock-Picking AI Predicts #1 Stock of 2024Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Shineco, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
